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Accepted 6 October 2015; Published online 10 November 2015AbstractObjective: Statistical interaction between a single, instantaneous exposure and attained age (age during follow-up; attained age 5 age
at exposure þ time since exposure) is used in risk analyses to assess potential effect modification by unmeasured factors correlated with
age. However, the impact of such interaction on the statistical distribution of age-at-onset of outcome (disease or death) is infrequently
assessed. We therefore explored the impact of such interaction on the shape of the onset-age distribution.
Study Design and Setting: We use for illustration age-at-onset of radiation-related early menopause in a cohort of female Japanese
Atomic Bomb Survivors. The statistical distribution of age-at-onset was derived from a parametric hazard rate model fit to the data,
assuming an underlying Gaussian onset-age distribution among nonexposed women.
Results: Commonly used forms of exposure-by-age (attained age) interaction led to unnatural estimates of the age-specific rate function
and unreasonable estimates of the onset-age distribution among exposed women, including positive risk of menopause before menarche.
Conclusion: We recommend that researchers examine the distribution of age-at-onset and exposure-age interaction when conducting
risk analyses. To distinguish this from potential etiologic interaction between exposure and unmeasured factors represented by age as a
surrogate, richer models or additional data may be required.  2016 The Authors. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cation or effect modification). Additivity is sometimes
regarded by epidemiologists as the appropriate scale for
assessing biological or mechanistic interaction [1], but the
scale on which joint effects of risk factors are analyzed
should be chosen according to biological considerations
[2,3]. Here, we consider a single, instantaneous exposure,
so the relation (attained age) 5 (age at exposure) þ (time
since exposure) holds. The term ‘‘age’’ refers to ‘‘attained
age’’ (age at risk during follow-up) throughout this article.
Because age is frequently the primary time scale of interest
with observational epidemiologic data [4], hazard rate
models for outcomes occurring in middle or older age, such
as chronic diseases, should generally incorporate some
interaction between exposure and age because the excess
absolute rate might not be constant in age. Furthermore,
examination of interactions between risk factors and age
is warranted when comparing multiplicative and additive
scales for risk [5].ess article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
 Statistical interaction between exposure and
attained age (age at exposure þ time since expo-
sure) has implications for the shape of the distribu-
tion of onset age in risk analyses. This seems to be
hardly recognized despite the frequent use of such
interaction for assessing potential effect modifica-
tion using age as a surrogate for unmeasured age-
related factors.
What this adds to what was known?
 We illustrate how exposure-by-age (attained age)
interaction affects the onset-age distribution among
exposed persons and show that it can produce
unnatural results, including a positive risk of
exposure-related outcome when the outcome is
physiologically not possible. Such results may go
unnoticed in standard analyses.
What is the implication and what should change
now?
 Using age as a surrogate to assess interaction
between exposure and unmeasured age-related fac-
tors requires greater consideration. In particular, an
exposure-by-age (attained age) interaction cannot
simultaneously capture both the effect of the exposure
on the onset-age distribution (statistical interaction)
and the risk-modifying effects of unmeasured age-
related factors (effect modification), rendering such
an interaction term difficult to interpret.
In other words, there may be constraints on the statistical
distribution of age-at-onset among exposed persons, but such
constraints are not routinely examined in standard epidemio-
logic risk analyses. A natural way to handle such constraints
is via an interaction between exposure and attained age in the
statistical model. However, attained age is also frequently
considered as a surrogate for unmeasured, underlying biolog-
ical processes that may interact mechanistically withdor
modify the effect ofdthe exposure, so the question arises
whether mechanistic interaction between exposure and age
as a surrogate can be distinguished from the need for the rate
to depend on age due to constraints on the onset-age distribu-
tion. Unfortunately, many studies involving a test of interac-
tion between exposure and age, where the interaction might
reflect age-related acceleration of onset in a subset of
the exposed individuals, do not mention this distinction
[6e12], and we could find few examples of the use of an
additive hazard rate model for testing interaction [13,14].
Although the age dependence of the risk can be visualized
using a plot of the rate (or hazard function), such a plottypically does not immediately convey features of the
onset-age distribution thatmight require constraints. Because
of direct connections between the cumulative incidence pro-
portion (the distribution function, also one minus the survival
function), hazard function, and onset-age distribution (the
density function), it is relatively straightforward to examine
a plot of the onset-age distribution derived from the output
of standard survival analyses. Doing so can reveal features
of the rate that constrain the statistical interaction between
exposure and age. We explore this issue with radiation-
related acceleration of age at menopause in the Life Span
Study cohort of female Japanese Atomic Bomb Survivors.
The results apply also to outcomes such as total mortality
or cancer incidence that have restricted ranges of age at occur-
rence of outcome. The results indicate the need for careful
interpretation of what is called ‘‘effect modification’’ by age.2. Methods
Consider the effect of a single, instantaneous radiation
exposure on subsequent female menopause, which in the
absence of exposure has an onset-age distribution limited
typically to about a decade in middle life (approximately be-
tween ages 4555 years). Radiation exposure to the ovaries
can result in loss of fecundity and early menopause due to
ovarian failure [15,16], and the LD50 of the human oocyte
is!2 Gy [17]. Sakata et al. [18] reported that atomic bomb
radiation exposure leads to accelerated age at menopause
among female survivors. Ignoring the competing risk of arti-
ficial menopause, which is related to radiation through uter-
ine myoma and other conditions leading to surgically
induced menopause [19], their model for the age-specific
incidence of natural menopause included a background rate
depending on attained age, city of residence at the time of
the bombing, year of birth, parity, smoking behavior, and
age at menarche, as well as an excess rate depending on
ovarian dose of radiation in weighted Gray (Gyw, using
weight 10 for the neutron component and weight 1 for the
gamma component). The excess rate also included a log-
linear modification term including age at exposure and a
quadratic function of the natural logarithm of attained age
(scaled to have value 0 at age 50 years). Cumulative inci-
dence proportionswere presented, with estimatedmedian ac-
celeration of age at menopause being 0.5 and 0.8 years for
women exposed to 1.0 and 1.5 Gyw, respectively, compared
with women exposed to under 0.4 Gyw and nonexposed
women combined, because a threshold of 0.4 Gyw was indi-
cated [[18], p. 793]. Their plot is essentially reproduced here
(Fig. 1A) based on a normal distribution approximation to the
menopause-age distribution among nonexposed women and
the model of Sakata et al. [18] for the risk among exposed
women (Fig. 1B). The normal approximation was used to
facilitate comparisons among the hazard ratemodel, cumula-
tive incidence proportion, and onset-age density function.
Fig. 1. (A) Cumulative incidence proportion of natural menopause according to the excess absolute rate model of Sakata et al. [18] with exponential
effect modification by a quadratic term in log of age. Solid line: women exposed to under 0.4 Gy or nonexposed; dashed line: women exposed to 1.0
Gyw. (B) Theoretical normal density (solid line) and actual density (dotted line) of age at menopause in the under 0.4 Gyw and nonexposed women
combined.
45S. Izumi et al. / Journal of Clinical Epidemiology 71 (2016) 43e50Two common models for the hazard rate are the excess
absolute rate (EAR) and excess relative risk (ERR) models,
whichmaybe defined simply according to the followingover-
all age-specific rate of outcome (incidence or mortality rate):overall rate at age a5 ðbackground rateÞ þ ðexcess absolute rateÞ5 ðbackground rateÞ þEAR
5 ðbackground rateÞ  ½1þEAR=ðbackground rateÞ
5 ðbackground rateÞ  ½1 þ ERR5 ðbackground rateÞ RRwhere RR is the relative risk (see the Appendix at www.
jclinepi.com for details and mathematical definition of these
rates). Because of the theoretical equivalence of the EAR and
ERR models, if no interaction exists with a particular back-
ground factor on one scale, theremust be interactionwith that
factor on the other scale [3,20]. For example, if the ERR de-
pends on neither age nor time, then the EAR (which is the
ERR multiplied by the background rate) would depend on
age and time to the same extent as the background rate. Note
that neither the EAR nor the ERRmodel is a standard propor-
tional hazards (Cox) model; nevertheless, these models can
be fit using standard methods that extend the Cox model
[21,22].
Using results from survival analysis regarding the math-
ematical relationships among the cumulative distribution
function F(t), survival function S(t) 5 1F(t), hazard (rate)
function h(t), and density function f(t) [23,24], where t is
any value of time on the time scale used in the analysis,
the density function isf ðtÞ5hðtÞSðtÞ: ð1Þ
Using attained age as the time scale, the density function
f(a) of ages at natural menopause in the nonexposed female
Atomic Bomb Survivors is approximately normal, except
for a small excess between ages 37e47 years (Fig. 1B),
so we assume a normal density among nonexposed womento simplify the illustration. We estimated the mean and
variance of the normal approximation using the data of Sa-
kata et al. [18] for women exposed to under 0.4 Gyw and
nonexposed women combined. In exposed women, the pre-dicted distribution of onset-age was calculated by fitting
either an EAR or ERR model, with no age modification
or with age modification using either a linear or quadratic
term in the log of age. Parameters of the hazard rate model
were estimated using the Poisson regression package for
person-year data ‘‘AMFIT’’ in the Epicure software [25],
using the original data [18], with confidence intervals in
Epicure calculated according to the profile-likelihood
method [26].
3. Results
The onset-age density derived from the EAR model with
quadratic age modification (Fig. 2A)dthe model used by
Sakata et al. [18]dsuggests that radiation acts to accelerate
onset ofmenopause among some, but not all, exposedwomen,
resulting in a spread toward younger values in the distribution
of ages at menopause. This is what we would predict from a
biological perspective because some women will respond to
radiation exposure and others will not [16], leading to a
widening of the onset-age distribution toward younger ages
but no decrease in the maximum of the age range (assuming
there is no beneficial effect of radiation exposure leading to
delayed onset of menopause). The quadratic effect modifier
(Fig. 3A) has a large negative coefficient (Table 1), which
results in essentially no exposure effect below age 35 years
and a lessening of exposure effect at ages close to the highest
part of the menopause onset-age distribution.
Fig. 2. Density functions for menopause onset age with the various exposure-by-age (attained age) risk-modifying functions. (A) Excess absolute
rate (EAR) model with quadratic age modification. (B) EAR model with linear age modification. (C) EAR model with no age modification. (D) Excess
relative risk (ERR) model with quadratic age modification. (E) ERR model with linear age modification. (F) ERR model with no age modification.
Solid lines: nonexposed women (including women exposed to under the threshold, 0.4 Gyw); dashed lines: women exposed to 1.5 Gyw.
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onset-age density shown in Fig. 2B. Here, the distribution
of age-at-onset appears as a shift, or uniform acceleration
of age at menopause among all exposed women, rather than
as an increase in dispersion. Thus, linear adjustment doesFig. 3. Exponentiated exposure-by-age (attained age) risk-modifying functi
model in an exponential term multiplying the radiation risk term). (A) Qu
(EAR) model. (B) Linear risk modification by attained age in the EAR model
risk (ERR) model. (D) Linear risk modification by attained age in the ERRnot reflect a random phenomenon affecting some, but not
all, exposed women. The reason is apparent from
Fig. 3B, where it is seen that the log-linear effect modifier
function increases exponentially with age, so that there will
be little impact of exposure at earlier ages but a largeons of log of attained age (log attained age was entered into the risk
adratic risk modification by attained age in the excess absolute rate
. (C) Quadratic risk modification by attained age in the excess relative
model.
Table 1. Radiation-effect and exposure-by-age (attained age) interaction estimates obtained from the data of Sakata et al. [18]
Model (scale)
Mathematical form
of age modifier
Radiation main effect Exposure-by-age interaction Goodness of fit
Parameter estimate 95% CIa Parameter estimate 95% CIa AIC
EAR (additive risk) Quadratic 35.1 22.1, 51.1 34.9 48.3, 23.9 12,329.048
Linear 33.6 18.5, 52.7 8.01 5.60, 10.4 12,348.609
None 3.14 1.43, 5.26 - - 12,375.518
ERR (multiplicative risk) Quadratic 0.165 0.059, 0.284 10.3 7.69, 19.2 12,383.740
Linear 0.190 0.101, 0.296 6.63 8.85, 4.20 12,366.988
None 0.173 0.059, 0.297 - - 12,383.748
Abbreviations: AIC, akaike information criterion; CI, confidence interval; EAR, excess absolute rate; ERR, excess relative risk.
a Profile-likelihood-based confidence intervals.
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fit the data as well as the quadratic modification model
(Table 1, goodness-of-fit measures). However, adding linear
interaction terms seems to be common practice in epidemi-
ologic data analyses; if the quadratic modification model
was not fit, the researcher would neither be aware of its bet-
ter fit to the data nor of its more natural derived onset-age
distribution.
The density function with no age adjustment in the
excess absolute rate model has an excess rate that is con-
stant in age, including immediately after menarche, which
seems unlikely, and even at ages before menarche, which
is physiologically impossible. A striking feature of the
excess absolute rate model without age modification is
the appearance of little radiation risk over the usual meno-
pausal age range (note the small radiation parameter in
Table 1). Thus, the effect of radiation exposure would be
missed if only a main effect of radiation, but no interaction
between exposure and age, was included in the model.
Because researchers frequently compare additive and
multiplicative models, it is of interest to consider how the
interaction between exposure and attained age operates in
the case of a multiplicative model for risk, such as the
ERR model. With this model, the effect of exposure is mul-
tiplicative, so the rate among exposed women cannot be
greater than zero when the background rate is zero, irre-
spective of whether there is age modification. As a result,
the ERR model can only result in an increased rate over
the range of ages in which natural menopause occurs in
nonexposed women: acceleration of risk of menopause
toward younger ages is therefore not possible with a multi-
plicative model (Fig. 2DeF). Furthermore, because of the
multiplicative relationship, without age modification, the
greatest effect of exposure occurs when the background rate
is highestdthat is, close to the end of the natural range of
menopause ages, when few women are premenopausal and
the rate of impending menopause is high (Fig. 2F). This
implies that relatively fewer exposed women will have nat-
ural menopause at ages close to the upper limit, which
seems unlikely if the menopause response to radiation
exposure is a stochastic phenomenon.
A quadratic age modifier of the ERR produces nearly the
same onset-age density as no age modification (Fig. 2D).
Because of the shape of the quadratic effect-modifyingfunction (Fig. 3C), which has a positive coefficient, the dif-
ference compared with no effect modification is small
between the ages of 40e60 years. A similar effect occurs
with the linear effect modifier (Fig. 3D). Thus, the pre-
dicted onset-age distributions with all three modification
scenarios are similar with the ERR model. In short, it does
not seem possible to achieve the intuitively desirable shape
of onset-age distribution among exposed women with rela-
tively simple functions for age interaction when using the
ERR model. One could use more general models in age,
such as splines, to modify the ERR, but quadratic adjust-
ment with the excess absolute rate model seems preferable
for its simplicity and ease of interpretation.4. Discussion
We have shown that a particular form of exposure-by-
age interaction (where ‘‘age’’ is attained age, the age at risk
during follow-up) may be required for valid modeling of
the onset-age distribution among exposed persons. For
studying radiation-associated acceleration of menopause,
an excess absolute rate model incorporating interaction
between exposure and an exponentiated quadratic function
of log of attained age is biologically reasonable and admits
a logical interpretation. This interaction between exposure
and attained age is required to handle natural constraints
on the statistical distribution of age-at-onset; similar inter-
pretation would apply to additive excess absolute rate
models for all-cause mortality and chronic disease inci-
dence among adults. If the model scale and mathematical
form of the exposure-by-age interaction were chosen on
the basis of statistical criteria alone, and there were unmea-
sured age-related factors that modified the risk (hence
inducing a separate exposure-by-age interaction in the
mechanism generating the data), it is conceivable that an
unnatural estimate of the onset-age distribution including
positive probability mass at unlikely ages could result,
causing implausible risks at certain ages. It is well known
that model selection should be based on subject-matter
criteria in addition to statistical criteria; indeed the latter
may be imperfect or lack power [27]. Although in principle
the additive and multiplicative models should be the same
[28], in practice, the results of fitting the two model scales
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testing interaction can differ between the two scales
[29,30]. Thus, choice of model scale based on interaction
tests and/or goodness-of-fit tests may not lead to the ‘‘cor-
rect’’ model. Statistical criteria should only be used as a
guide to clarifying biologically meaningful models, not as
a means to selecting models haphazardly without regard
to their biological interpretation.
The possible need for statistical interaction between
exposure and age to capture the effect of exposure on the
onset-age distribution is at odds with the fact that such
an interaction is often used in epidemiologic analyses to
test for interaction between exposure and unmeasured fac-
tors that are correlated with age. When assessing the
exposure-by-age interaction for purposes of studying such
effect modification, the resulting (typically unexamined)
estimated onset-age distribution may lead to implausible
risk estimates at certain ages. If there are unmeasured fac-
tors correlated with age that interact mechanistically with
exposure to modify the rate, interactions between them
and exposure cannot be assessed except using age as a sur-
rogate effect modifier. This results in conflicting needs,
both of which are handled via the same modeling approach:
statistical interaction between exposure and attained age.
Because a single interaction term cannot simultaneously
capture both types of interaction, it may be difficult to inter-
pret the estimated interaction parameter. To allow interpre-
tation of that parameter (and indeed to estimate a
biologically plausible onset-age distribution), one or the
other interaction would have to be treated explicitly. One
approach would be a richer statistical model including a
component for the impact of exposure on onset age. For
example, if age dependence of the menopause onset-age
distribution in exposed women is due to radiation-related
depletion of oocytes [15], incorporating a dose-dependent
depletion model might obviate the need for statistical
adjustment via an interaction between exposure and age,
so that mechanistic effect modification by unmeasured
age-related factors could be considered using such an inter-
action term. Another approach would be to collect actual
data on age-related factors hypothesized to modify expo-
sure risk, so that the exposure-by-age interaction could be
used solely for estimating a valid onset-age distribution.
Age and time per se are not generally factors that oper-
ate themselves on the mechanisms of clinical outcomes.
However, age and time are often used as surrogates of
underlying mechanisms with which they are correlated.
For disease incidence and mortality in general, these mech-
anisms might include preadolescent, periadolescent, and
postadolescent factors in the case of young age at exposure,
the accumulation over time of exposures to other risk fac-
tors and effect-modifying factors in the case of time since
exposure, and the effect of aging on immune function,
genomic instability, and other aging processes in the case
of attained age. Although age and time are useful for
assessing effect-measure modification in the absence ofactual data on such underlying factors, collinearity induced
by the relation (attained age) 5 (age at exposure) þ (time
since exposure) leads to the need for caution when inter-
preting effect modification using age and time variables
[31]. Ideally one would like to have measurements of the
actual factors that modify the effect of exposure, but in
practice, such factors may be difficult to assess assuming
that they can even be identified. Given the potential need
to carefully model exposure-by-age interaction to correctly
capture the impact of age on risk and the resulting onset-
age distributiondas demonstrated in this reportdfailure
to account for age-related effect modifiers could result in
invalid inference regarding risk due to a misspecified
onset-age distribution among exposed persons. Although
not directly related to the issue of onset-age distribution,
a numerical example demonstrates how failure to adjust
for effect modification by age leads to bias in the estimated
exposure risk for another age-related variable [32].
The need for an exposure-by-age interaction to accom-
modate the effect of exposure on the statistical distribution
of age-at-onset is different from the issue of parsimony [5].
With data where the underlying true effect of exposure is a
constant relative risk (i.e., no interaction on the multiplica-
tive scale), interaction between exposure and age would be
required in an additive excess absolute rate model [30,33].
However, as noted herein, assuming no age interaction is
equivalent to making a very restrictive assumption about
the effect of the risk factor on the onset-age distribution,
and, in our example, with a relative risk model that restric-
tion could not be easily relaxed using a simple mathemat-
ical form of statistical interaction between exposure and
age. It is also conceivable that such interaction might not
be statistically significant in a small sample although
required on substantive grounds. Therefore, careful consid-
eration of the (1) effect of exposure on the onset-age distri-
bution among exposed persons and (2) interaction between
exposure and risk-modifying effects of unmeasured age-
related factors may be more important than requiring parsi-
mony in the hazard rate model.
Early onset of menopause is not the only concern related
to radiation exposure to the ovaries. The possibility of genetic
effects is an ongoing topic of investigation [34e36]. Where
acceleration of age at menopause is of concern, however,
our analysis suggests that attention should be given to more
than just the age-specific rate. Visualization of the onset-
age distribution via the density function is revealing and
instructive and can be achieved using information available
from the output of standard survival analyses. The large vari-
ation in age at menopause may be due in part to variation in
ovarian reserve, although other factors (including body mass
and smoking) may also play a role [37].
The results of the present investigation provide further
justification for the use of age as the primary scale in the anal-
ysis of long-term follow-up studies [4,38], in that it allows
direct inspection of the onset-age distribution. If a statistical
interaction between exposure and attained age is required to
49S. Izumi et al. / Journal of Clinical Epidemiology 71 (2016) 43e50deal with age dependence of the onset-age distribution
among exposed persons, there is little hope of distinguishing
that interaction from effect modification by age-related fac-
tors unless one or the other can be modeled explicitly. Our
results would also apply to cancer and other chronic diseases
that involve constraints on the onset-age distribution (e.g.,
breast cancer, which has an onset-age distribution similar
in form, but wider, compared with that of menopause [39]).
Because interaction with attained age is frequently consid-
ered in hazard rate models, we believe that examination of
how the onset-age distribution is determined by the statistical
model iswarranted in addition to visualization of hazard rates
and/or cumulative incidence proportions. What impact an
unmeasured age-related effect modifier would have on the
estimated exposure-by-age interaction might depend on
many things, including the strength of effect modification
and the distribution of the unmeasured factor. That is a topic
for further research via simulation.Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2015.10.004.
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